Skip to main content
Caplight Logo









Restore Medical Ltd.

Restore Medical Ltd.

Private
Or YehudaHealthcare & Life Scienceshttps://restoremedical.co/

Last Round

Series B

Jul 7, 2025

Total Funding Raised

$34.63M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Restore Medical Ltd. is a therapeutic devices company developing the ContraBand, a minimally-invasive, catheter-delivered implant for the treatment of congestive heart failure (CHF).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

heart failure devicetranscatheter therapycongestive heart failureCHFHeart Failure with reduced Ejection FractionHFrEFminimally invasive devicepulmonary artery bandinginterventional cardiologystructural heart devicemedtechFDA breakthrough deviceclinical-stage companyreversible therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Restore Medical Ltd. Comparables

Compare Restore Medical Ltd. with similar companies based on industry and business-model similarity.

Restore Medical Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ancora Heart
86%
Adona Medical
84%
Alleviant Medical
79%

Restore Medical Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 7, 2025
GrantJun 28, 2022
SeedDec 7, 2021

Key People

Founding team and executive leadership

Stephen Bellomo

CTO, Co-Founder

Founding Team

Restore Medical Ltd. Investors

Notable investors and investment history

Restore Medical Ltd. investors
InvestorRounds
Allegro Venture PartnersSeed
Peregrine VenturesSeed, Series B
Incentive IncubatorSeed
European Innovation Council FundGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 618% MoM, reaching 948.

  • Apr 18, 2026

    Grew 20% QoQ, from 15 to 18 employees.

Restore Medical Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Restore Medical Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Restore Medical Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersOr Yehuda
Employee Range19
Year Founded2015
Last FundingJul 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?